
Clinica Baviera S.A (CBAV) | Stock Overview & Key Data
Clinica Baviera S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €45.40 on July 16, 2025
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Clinica Baviera S.A CBAV | 698.18M Mid-cap | 0.69% | 0.46% | 17.02% | 24.29% | 39.68% | 53.31% | 113.59% | 394.38% |
Pangaea Oncology PANG | 58.60M Small-cap | 0.00% | 1.78% | 1.18% | -1.71% | -2.82% | 17.01% | 17.81% | 59.26% |
EuroEspes S.A EEP | 6.26M Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.85% | 35.00% |
Grifols, S.A GRF | 7.93B Large-cap | -2.06% | 22.50% | 57.28% | 54.08% | 35.84% | 46.52% | -6.61% | -47.55% |
Laboratorios ROVI | 2.72B Large-cap | -2.03% | -3.37% | 3.41% | -4.32% | -17.03% | -32.16% | 1.36% | 86.38% |
Almirall S.A ALM | 2.20B Large-cap | -3.21% | -4.12% | 0.20% | 13.15% | 22.20% | 14.03% | 4.28% | 7.11% |
Ownership & Short Interest
Clinica Baviera S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Clinica Baviera S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CBAV's 52-week high and low?
- In the last 52 weeks, Clinica Baviera S.A reached a high of €45.40 (on July 16, 2025) and a low of €28.30 (on August 8, 2024).
- What is the market cap and P/E ratio for CBAV?
- Curious about Clinica Baviera S.A's size and valuation? Its market capitalization stands at 698.18M. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.17, and the forward P/E (looking ahead) is 24.77.
- Does CBAV pay dividends? If so, what's the yield?
- Yes, Clinica Baviera S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 7.97%, and the company has paid an average of €1.48 per share annually over the past 3 years.
- Who are Clinica Baviera S.A's main competitors or similar companies to consider before investing?
When looking at Clinica Baviera S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Pangaea Oncology
PANG58.60M Healthcare Diagnostics & Research 17.01% 17.81% EuroEspes S.A
EEP6.26M Healthcare Diagnostics & Research 0.00% 3.85% Grifols, S.A
GRF7.93B Healthcare Drug Manufacturers - General 46.52% -6.61% Laboratorios
ROVI2.72B Healthcare Drug Manufacturers - Specialty & Generic -32.16% 1.36% Almirall S.A
ALM2.20B Healthcare Drug Manufacturers - Specialty & Generic 14.03% 4.28% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Clinica Baviera S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Clinica Baviera S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 46.33%, the Debt to Equity ratio from the most recent quarter is 70.72, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for CBAV?
- Looking at Clinica Baviera S.A's growth, its revenue over the trailing twelve months (TTM) was €289M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.00%, and quarterly earnings saw a YoY growth of -9.80%.
- How much of CBAV stock is held by insiders and institutions?
- Wondering who owns Clinica Baviera S.A stock? Company insiders (like executives and directors) hold about 85.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 5.55%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.